Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00138294 · ClinicalTrials.gov registry record · Phase 4
Control of Epidemic Influenza Through a School-based Influenza Vaccination Program
A Phase 4 study, sponsored by Baylor College of Medicine.
- Completed
- Registry status
- Phase 4
- Development phase
- 29,255
- Enrollment target
NCT00138294: Completed Phase 4 study, sponsored by Baylor College of Medicine.
NCT00138294 is a Phase 4 study that has completed, run by Baylor College of Medicine. The registered enrollment target is 29,255 participants, above the 515-participant average among 9,235 other Phase 4 trials with a reported enrollment target (5581% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00138294, a Phase 4 study, has completed, sponsored by Baylor College of Medicine.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 29,255 participants
- Enrollment target
Study Summary
The main purpose of this study is to learn if influenza vaccines (live attenuated and inactivated influenza vaccines), when given to school-aged children 4 to 18 years of age, can stop or lessen the influenza (flu) outbreak in the community. Another purpose is to show that vaccination of these children will significantly reduce breathing problems (in the vaccinated children and unvaccinated people they come in contact with in the community) that require a visit to the doctor for treatment. Another purpose is to continue to collect safety and flu protection information on live attenuated influenza vaccine (LAIV or FluMist) given to children. The study investigators believe that vaccination of healthy school-aged children is an effective plan for preventing many people in the community from catching the flu. Children will take part in the study for 5 to 10 months.
Primary Outcome
The rate of MAARI (MAARIs/1000 persons-week) were compared between the intervention and comparison cities during the epidemic period (irrespective of the vaccination status). This data was obtained from the SWHP database.
Interventions
- BIOLOGICAL live attenuated and inactivated influenza vaccines
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 29,255 participants |
| Start Date | 1998-10 |
| Est. Completion | 2010-06 |
| Phase | Phase 4 |
What the finished NCT00138294 record still lists
NCT00138294 is an interventional study that assigns participants to a tested intervention. Its 29,255 participants enrollment target places it among the larger protocols in the corpus, above the 515-participant average among 9,235 other Phase 4 trials with a reported enrollment target (5581% higher).
The record links to 0 conditions, and to 1 intervention - of which live attenuated and inactivated influenza vaccines is the first listed.
NCT00138294 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00138294 about?
NCT00138294 is a clinical study titled "Control of Epidemic Influenza Through a School-based Influenza Vaccination Program". The main purpose of this study is to learn if influenza vaccines (live attenuated and inactivated influenza vaccines), when given to school-aged children 4 to 18 years of age, can stop or lessen the influenza (flu) outbreak in the community. Another purpose is to show that vaccination of these child...
What is the current status of trial NCT00138294?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 29,255 participants. The study started on 1998-10. Estimated completion is 2010-06.
What interventions are being tested in trial NCT00138294?
The interventions under investigation include: live attenuated and inactivated influenza vaccines (BIOLOGICAL).
Who is sponsoring clinical trial NCT00138294?
This trial is sponsored by Baylor College of Medicine, which has 616 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00138294's enrollment target sits among peer trials
29,255 5th of 2000 higher than 1,996 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00684580 · 30,000 participants
Protocol For Collecting Data On Patients With Childhood Cancer
- NCT03053193 · 30,000 participants
MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles
- NCT03689595 · 30,000 participants
Predicting Progression of Developing Myeloma in a High-Risk Screened Population (PROMISE)
- NCT04834869 · 30,000 participants
COVID-19 Vaccines Safety Tracking (CoVaST)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia